A BPC-157/TB-500 blend combines two peptides researched for tissue repair. BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4 fragment) are often used together in research due to their complementary mechanisms supporting recovery.

Research protocols commonly use blends providing 250-500 mcg BPC-157 and 500-1000 mcg TB-500 per dose, administered subcutaneously 1-2 times daily. Cycles typically run 4-8 weeks.

Research protocols vary — some administer subcutaneously near the area of interest while others use standard injection sites like the abdomen. BPC-157 has shown systemic activity in studies regardless of injection location.